Mar 5
Atea anticipates top line Phase III HCV results midyear 2026 while advancing HEV program
Synthesized from 1 source
Sources (1)
Bias Scale:
LeftCenterRight
Seeking AlphaMar 5, 2026, 11:57 PM
Atea anticipates top line Phase III HCV results midyear 2026 while advancing HEV program80High Trust
Comments
No comments yet. Be the first!